COMPANY:"Using Voice to Save Lives", Cardiokol is a privately-owned digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations.We offer revolutionary affordable, scalable, long-term and age-friendly monitoring solutions.Our technology is applicable for mass at-risk populations including older adults (65+), by utilizing proprietary technology that is implemented in speech platforms such as landlines, smartphones, smart speakers and voice assistants.Cardiokol long-term strategic offering is a novel platform and a suite of solutions which allow for the first time wide scale prevention of multiple conditions, starting with Afib including prevention of acute and chronic dire complications (stroke, cardiac and kidney failure and more), at a later stage Arrhythmias, Heart diseases and Acute Chronic diseases. TECHNOLOGY:Cardiokol technology extracts and identifies vocal parameters that are associated with the irregularity of heartbeat.Our proprietary algorithms are based on explicit signal processing techniques and artificial intelligence (neural networks models) that were established with our growing clinical database of Atrial Fibrillation and normal heart rhythm vocal recordings with matched ECG patient recordings. PRODUCT:Cardiokol’s Proprietary solution: VAAM – Voice Assist Arrhythmia Monitoring. Software-based, vocal markers to scale Afib detection through existing, daily voice user interfaces.The product is approved as CE Medical Device.• Increases typical detection yield X100’s %• Significantly improves disease managementTherefore, it prevents Millions of Strokes! BENEFITS:• Brings value to all major stakeholders- HMO’s, Insurance...• Is based on scalable technology which addresses all patient segments• Provides solutions to cover all parts of the patient journey over time